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BRIEF DEFINITIVE REPORT
Sphingosine-1-phosphate receptor 2 restrains egress
of γδ T cells from the skin
Brian J. Laidlaw1,2*, Elizabeth E. Gray1,2*, Yang Zhang1,2, Francisco Ramı´rez-Valle1,2, and Jason G. Cyster1,2
Maintenance of a population of IL-17–committed γδ T cells in the dermis is important in promoting tissue immunity. However,
the signals facilitating γδ T cell retention within the dermis remain poorly understood. Here, we find that sphingosine-1-
phosphate receptor 2 (S1PR2) acts in a cell-intrinsic manner to oppose γδ T cell migration from the dermis to the skin
draining lymph node (dLN). Migration of dermal γδ T cells to the dLN under steady-state conditions occurs in an S1PR1-
dependent manner. S1PR1 and CD69 are reciprocally expressed on dermal γδ T cells, with loss of CD69 associated with
increased S1PR1 expression and enhanced migration to the dLN. γδ T cells lacking both S1PR2 and CD69 are impaired in their
maintenance within the dermis. These findings provide a mechanism for how IL-17+ γδ T cells establish residence within the
dermis and identify a role for S1PR2 in restraining the egress of tissue-resident lymphocytes.
Introduction
Protection of the skin against physical insults and microbial
invasion is critical to the long-term health of the host. The
skin contains a diverse array of immune cells that function
cooperatively to facilitate tissue repair and host defense, along
with a multitude of microorganisms that are essential in
regulating skin immunity and inflammation (Lai et al., 2009;
Naik et al., 2012; Ridaura et al., 2018). Recently, a population
of dermal γδ T cells has been identified in both mice and
humans (Cai et al., 2011; Gray et al., 2011; Sumaria et al., 2011).
Most dermal γδ T cells are CCR6+, arise from Sox13-expressing
progenitors, and are precommitted to express IL-17 (Gray
et al., 2013; Spidale et al., 2018). They maintain themselves
within the skin and are dependent on IL-7, but not IL-15, for
their self-renewal with mouse dermal γδ T cells expressing a
TCR containing either Vγ4 or Vγ6 (Gray et al., 2011, 2013;
Sumaria et al., 2011). Dermal γδ T cells are a primary source of
IL-17 following skin infection with pathogens such as Myco-
bacterium bovis and are critical for neutrophil recruitment to
the skin and eventual pathogen clearance (Sumaria et al.,
2011; Nakamizo et al., 2015; Ramı´rez-Valle et al., 2015). They
are also a major source of IL-17 in psoriatic skin lesions with
increased IL-17 expression correlating with disease progres-
sion (Gatzka et al., 2013; Gray et al., 2013). Acute depletion of
γδ T cells results in protection in an induced psoriasis model
(Sandrock et al., 2018).
While γδ T cells are motile and largely resident within the
dermis, they undergo a low rate of trafficking to the skin
draining LN (dLN) under steady-state conditions (Gray et al.,
2011, 2013; Jiang et al., 2017). Flux of γδ T cells from the der-
mis to the dLN increases under conditions of inflammation, with
CCR2 contributing to the migration of γδ T cells expanded in the
dLN back to the inflamed sites (Gray et al., 2013; Ramı´rez-Valle
et al., 2015; McKenzie et al., 2017). Within the dLN, γδ T cells
migrate in close association with the subcapsular sinus in a
CCR6-dependent manner (Zhang et al., 2016). γδ T cells can also
travel to noninflamed dermis and distant LNs, where they are
maintained at elevated numbers for months and display en-
hanced responsiveness upon stimulation (Ramı´rez-Valle et al.,
2015; McKenzie et al., 2017). γδ T cells expanded in the dLN are
important for protection against Staphylococcus aureus skin re-
infection (Dillen et al., 2018).
The constant motility of dermal γδ T cells facilitates sur-
veillance of the dermis for commensals and invading pathogens
(Gray et al., 2011; Ridaura et al., 2018). Maintaining a sufficient
density of γδ T cells within the dermis is likely to be essential to
allow patrolling cells to rapidly detect invaders. Therefore, while
migration of dermal γδ T cells to the dLN may be useful to es-
tablish a γδ T cell population in the LN that can protect against
pathogens that bypass the skin, it is important that sufficient
cells are retained in the dermis to maintain barrier immunity
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(Nakamizo et al., 2015; Davies et al., 2017). The signals mediating
γδ T cell retention in the dermis are not yet defined.
Skin lymphatics produce CCL21, sphingosine-1-phosphate
(S1P), and other chemoattractants such as CXCL12 (Gunn et al.,
1998; Kabashima et al., 2007; Pappu et al., 2007). Cell exit from
skin via lymphatics can be mediated by CCR7 in the case of
dendritic cells and naive T cells or S1P receptor 1 (S1PR1) in the
case of effector or memory T cells (Ohl et al., 2004; Debes et al.,
2005; Skon et al., 2013). Tissue-resident memory CD8+ T (TRM)
cells are often characterized by expression of CD69, a repressor
of S1PR1, and removal of CD69 from the cells can result in their
S1PR1-mediated loss from the tissue (Shiow et al., 2006;
Bankovich et al., 2010; Lee et al., 2011; Mackay et al., 2013, 2015;
Skon et al., 2013). Whether CD69 has a role in γδ T cell retention
in the skin is not known.
Here, we discover a role for S1PR2, a Rho-activating migra-
tion inhibitory S1PR (Takuwa et al., 2011; Green and Cyster,
2012), in restraining egress of γδ T cells from the dermis. We
also find that CD69 restricts expression of S1PR1 on dermal γδ
T cells and accordingly opposes migration of these cells from the
dermis. We propose a model in which S1PR2 functions to pre-
vent CD69 expressing γδ T cells from exiting the dermis, thereby
limiting egress under steady-state conditions to the small pro-
portion of cells that are able to sufficiently express S1PR1 to
escape S1PR2-mediated confinement.
Results and discussion
Accumulation of CCR6+ γδ T cells in the dLN of mice lacking
sphingosine kinase (Sphk) activity
To examine the role of S1P in γδ T cell positioning, we inter-
crossed Mx1Cre mice with animals carrying floxed and null alleles
of sphingosine kinase 1 (Sphk1) and null alleles of Sphk2. Neonatal
poly(I:C) treatment of these mice induces Cre expression and
ablation of the remaining Sphk1f allele, causing plasma S1P to de-
crease to undetectable levels (Pappu et al., 2007). These Sphk1/2-
deficient mice (referred to henceforth as Sphk1/2−/− mice)
displayed a marked increase in the frequency and number of
CCR6+, but not CCR6−, γδ T cells present in the skin dLN
(Fig. 1 a). Sphk1/2−/− mice had a decreased number of TCRβ+
cells in the dLN, possibly due to the role of S1P in promoting
naive T cell survival and mitochondrial function (Mendoza
et al., 2017; Fig. 1 a). While the frequency of CCR6+ γδ T cells
was similar in the dermis of Sphk1/2−/− and control mice, we
found that there was increased proliferation of dermal
CCR6+ γδ T cells in the Sphk1/2−/− mice (Fig. 1, b and c; gating
shown in Fig. S1 a). Increased proliferation was not evident
in the dLN CCR6+ γδ T cells or in dermal TCRβ+ cells or
dendritic epidermal T cells (Fig. 1 c and Fig. S1 b). Mice in
which Sphk activity was ablated in the lymphatic endothe-
lium similarly displayed an increased frequency of CCR6+ γδ
T cells in the dLN but not dermis, consistent with the notion
that lymphatic endothelial cells are an important in vivo
source of S1P (Pham et al., 2010; Fig. S1, c and d). Together,
these data indicate that S1P may oppose the accumulation
of CCR6+ γδ T cells in the skin dLN, with the increased flux
of cells from the dermis compensated by an increased
proliferation rate. It is also possible that this result could be due to
a role for S1P in facilitating the egress of CCR6+ γδ T cell from the
skin dLN.
S1PR2 restrains CCR6+ γδ T cell migration from the skin
S1PR2 is a G protein–coupled receptor that signals through Gα13
to promote migration inhibition in some cell types (Michaud
et al., 2010; Green et al., 2011; Takuwa et al., 2011). The find-
ing that S1P restrained the accumulation of γδ T cells in skin dLN
led us to ask whether S1PR2 might control γδ T cell egress from
the skin. Expression of S1pr2 mRNA was detected in CCR6+ γδ
T cells in the dermis and dLN, with analysis of Venus intensity in
S1pr2Venus/+ reporter mice showing higher expression of S1pr2 in
CCR6+ γδ T cells relative to their CCR6− counterparts (Fig. 2 a).
S1P inhibited the migration of dermal CCR6+ γδ T cells toward
CXCL12 in a dose-dependent manner, with this inhibition re-
versed upon coincubation with the S1PR2 antagonist JTE-013
(Fig. 2 b). This inhibition was not evident in CCR6+ γδ T cells
from the dLN (Fig. 2 b). Similarly, while S1P inhibited the mi-
gration of dermal CCR6+ γδ T cells from S1pr2+/− mice toward
CXCL12, this inhibition was absent in cells from S1pr2−/− mice
(Fig. 2 c).
S1pr2−/− mice displayed an increase in the frequency and
number of CCR6+ γδ T cells present in the skin dLN (Fig. 2 d).
This increase was evident as early as 7 wk and was maintained
across all ages examined (Fig. S2 a). There was no difference
in the number of CCR6− γδ T cells or TCRβ+ cells in the dLN
(Fig. 2 d). There was an increase in the number of IL-17+, but
not IL-17−, γδ T cells in the dLN, with this accumulation not
evident in the spleen, blood, adult thymus, or neonatal thymus
(Fig. 2 e and Fig. S2 b). The increase in γδ T cell frequency in
S1pr2−/− mice was evident in both Vγ4+ and Vγ4− subsets (Fig.
S2 c). We found that while the frequency and number of
CCR6+ γδ T cells was similar in the dermis of S1pr2−/− and
control mice, S1pr2−/− cells demonstrated an increased prolif-
eration rate (Fig. 2, f and g; and Fig. S2 d). There was no dif-
ference in the frequency or number of dermal TCRβ+ cells or
in the frequency of dermal CD45+ cells or CD11b+ cells (Fig. S2
d). Increased proliferation of CCR6+ γδ T cells was not ap-
parent in the dLN (Fig. 2 g). The smaller increase in dLN
CCR6+ γδ T cells in S1pr2−/−mice than in Sphk1/2−/−mice might
be because γδ T cells in mice selectively lacking S1PR2 have
some ability to exit the LN in response to S1P, whereas this
cannot occur in S1P-deficient mice.
We next tested whether S1PR2 acts in a cell-intrinsic manner
to regulate CCR6+ γδ T cell accumulation by reconstituting le-
thally irradiated mice with S1pr2−/− or S1pr2+/− neonatal thymo-
cytes and an equal number of congenically distinct control
neonatal thymocytes, as well as control bone marrow (BM).
Neonatal thymocytes are capable of efficiently reconstituting the
CCR6+ γδ T cell population (Gray et al., 2011). We found that
S1pr2−/− cells displayed a competitive advantage in repopulating
the CCR6+ γδ T cells found in the dLN, while being equivalently
represented among dermal CCR6+ γδ T cells and dLN TCRβ+ cells
(Fig. 2 h).
As an approach to test the sufficiency of S1PR2 to inhibit
T cell egress from tissue into lymphatics, we used a method that
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measures the impact of receptor overexpression on egress from
LNs (Pham et al., 2008). S1PR2 or empty vector (EV)–transduced
T cells were transferred into congenically distinct mice. The
recipient mice were treated with αL and α4 integrin–blocking
antibodies the following day to inhibit further entry into LNs,
and the frequency of transduced cells in the LNs was assessed
at the time of treatment (t = 0 h) and 18 h later (t = 18 h; Pham
et al., 2008). While EV-transduced cells displayed a similar
percentage of reporter+ cells in the LNs at both time points,
S1PR2-overexpressing cells were enriched in the LNs at t = 18 h,
indicating that S1PR2 can inhibit T cell exit from tissue via
lymphatics (Fig. S2 e). These findings also indicate that the ac-
cumulation of CCR6+ γδ T cells in the dLN of S1pr2−/− mice was
not because S1PR2 contributes to egress of these cells from
the dLN.
We next examined whether S1pr2−/− γδ T cells had an en-
hanced ability to migrate from the skin to the dLN using green-
to-red photoconvertible KikGR protein-expressing transgenic
mice. 10-min exposure of the ear skin of these mice to 415-nm
violet light is sufficient to induce photoconversion specifically
among ear skin cells with no measurable induction of inflam-
mation (Nowotschin and Hadjantonakis, 2009; Gray et al., 2013).
We analyzed the number of KikGR Red+ cells present in the dLN
24 h after photoconversion of the ear skin and found that
S1pr2−/− γδ T cells displayed an enhanced ability to migrate from
the dermis to the dLN (Fig. 2 i). γδ T cells that migrate from the
skin to the dLN after photoconversion are largely Vg4+ cells
expressing CCR6 (Nakamizo et al., 2015). The migrating γδ
T cells in S1pr2−/−mice remained predominantly Vg4+ (Fig. S2 f).
Together, these data indicate a model in which S1PR2 acts, in a
cell intrinsic manner, to restrain dermal CCR6+ Vg4+ γδ T cells
that sense S1P from egressing the skin.
CCR6+ γδ T cell migration from the skin is sensitive to S1PR1
functional antagonism
We next sought to explore the cues promoting CCR6+ γδ T cell
egress from the skin under steady-state conditions. Unlike
dendritic cells or naive TCRβ+ cells, dermal γδ T cell migration
from the skin to the dLN occurs in a CCR7-independent manner
(Vrieling et al., 2012; Nakamizo et al., 2015). These findings led
us to consider a role for S1PRs. Although our initial studies had
shown γδ T cells accumulated in the skin dLN of Sphk1/2−/−mice,
it seemed possible that S1P might cooperate with another lym-
phatic cue, such as CXCL12 (Kabashima et al., 2007), to mediate
skin egress. CCR6+ γδ T cells in the dermis and dLN express S1pr1
and S1pr4, and have intermediate expression of S1pr5 and low
expression of S1pr3 (Fig. 3 a). To examine the role of S1PRs in γδ
T cell migration from skin to dLNs, KikGR-transgenic mice were
treated with FTY720 or a vehicle control for 1 wk before expo-
sure of the ear skin to 415-nm violet light. FTY720 is a functional
antagonist of S1PR1 and has also been shown to engage S1PR2,
S1PR3, S1PR4, and S1PR5 (Brinkmann et al., 2010; Sobel et al.,
2015). FTY720-treated mice displayed a dramatic impairment in
the frequency of KikGR Red+ γδ T cells present in the dLN 1 d
later (Fig. 3 b).
S1pr1 mRNA was more highly expressed in CCR6+ γδ T cells
from the dLN relative to the dermis (Fig. 3 a). Moreover, while
S1PR1 protein was expressed by most CCR6+ γδ T cells in the
dLN, it was expressed on the surface of only a small subset of
dermal CCR6+ γδ T cells (Fig. 3 c). These data provided cor-
relative evidence that S1PR1 was involved in the skin egress of
CCR6+ γδ T cells. To test for a specific role for S1PR1 in CCR6+
γδ T cell trafficking, KikGR-transgenic mice were treated with
AUY954, a selective S1PR1 functional antagonist (Pan et al.,
2006), 1 d before exposure of the skin to violet light. AUY954-
treated mice displayed a marked impairment in the frequency
of KikGR Red+ γδ T cells present in the dLN 1 d later (Fig. 3 d).
Thus, while other lymphatic cues may be able to facilitate skin
egress when S1PR2-mediated confinement is absent, our
findings reveal that S1PR1 is critical for γδ T cell egress from
the dermis under normal conditions. The most straightfor-
ward explanation for these findings is that S1PR1 is func-
tioning intrinsically with the γδ T cells, though we cannot
fully exclude the possibility that some actions of the S1PR1-
modulating drugs are through other S1PR1-expressing cell
types.
Figure 1. CCR6+ γδ T cell accumulation in the
skin dLN is enhanced in Sphk-deficient mice.
(a) Representative FACS plots of CCR6+ TCRγδ+
cells (left) and numbers of CCR6+ and CCR6–
TCRγδ+ cells (middle) in the dLN of control and
Sphk1/2−/− mice. Numbers of TCRβ+ cells in the
dLN are shown on the right. (b) Percentage of
CCR6+ TCRγδ+ cells in the dermis of control and
Sphk1/2−/− mice. Data are pooled from six inde-
pendent experiments with one to three mice per
group. (c) Percentage of BrdU+ cells among the
CCR6+ TCRγδ+ population in the dermis (left)
and dLN (right) of control and Sphk1/2−/− mice.
Data are pooled from four independent experi-
ments with one to three mice per group. Sta-
tistical analyses were performed using the
unpaired two-tailed Student’s t test. *, P < 0.05;
**, P < 0.01; ***, P < 0.001.
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CD69 restricts S1PR1 expression and promotes CCR6+ γδ T cell
retention in the dermis
We next probed how S1PR1 function was regulated on dermal
CCR6+ γδ T cells. CD69 is a known repressor of S1PR1, with
deficiency of CD69 resulting in S1PR1-mediated loss of CD8+ TRM
cells from the tissue (Shiow et al., 2006; Bankovich et al., 2010;
Lee et al., 2011; Mackay et al., 2013, 2015; Skon et al., 2013).
CCR6+ γδ T cells in the dermis expressed increased Cd69mRNA,
and CD69 protein expression was only notable on dermal CCR6+
γδ T cells (Fig. 4, a and b). Suggestively, CD69 and S1PR1 were
reciprocally expressed on dermal CCR6+ γδ T cells (Fig. 4 b).
CCR6+ γδ T cells from the dermis, but not dLN, of Cd69−/− mice
displayed increased expression of S1PR1, leading us to hypoth-
esize that CD69 promotes CCR6+ γδ T cell retention in the dermis
(Fig. 4 c). Indeed, Cd69−/− mice displayed a marked increase in
the frequency and number of CCR6+ γδ T cells present in the
skin dLN (Fig. 4 d). The increase in γδ T cell frequency in Cd69−/−
mice was present in both Vγ4+ and Vγ4− subsets, although it
only reached statistical significance in the Vγ4− subset (Fig. S2 g).
There was no difference in the number of CCR6− γδ T cells or
TCRβ+ cells in the dLN (Fig. 4 d). The frequency and number of
CCR6+ γδ T cells was similar in the dermis of Cd69−/− and control
mice, with CCR6+ γδ T cells in the dermis, but not dLN, under-
going increased proliferation (Fig. 4, e and f; and Fig. S2 h). There
was no difference in the frequency or number of dermal TCRβ+
cells or in the frequency of dermal CD45+ cells or CD11b+ cells
(Fig. S2 h). We exposed the ear skin of Cd69−/− and control
KikGR-transgenic mice to violet light and observed an increase
Figure 2. S1PR2 acts in a cell-intrinsic manner to restrain CCR6+ γδ T cell migration from the skin. (a) Expression of S1pr2 in CCR6+ TCRγδ+ cells from
the dermis or dLN quantified by RT-PCR (sorted cells, left) or in CCR6+ and CCR6– TCRγδ+ cells by flow cytometry using S1pr2Venus/+ mice (right). Venus
expression in S1pr2+/+ mice was used as a negative control. Venus expression in germinal center B cells (B220+IgDloCD95+) is shown for comparison. mRNA
expression is pooled from two independent experiments with two or three mice per group. Venus expression is representative of five experiments with one or
two mice per experiment. (b) Percentage migration of CCR6+ TCRγδ+ cells from the dermis (left) or dLN (right) toward the indicated agents using a transwell
system. Data are pooled from three independent experiments. (c) Percentage migration of CCR6+ TCRγδ+ cells from the dermis of S1pr2+/− or S1pr2−/− mice
toward the indicated agents using a transwell system. Data are pooled from two independent experiments with two mice per group. (d) Representative FACS
plots of CCR6+ TCRγδ+ cells (left) and numbers of CCR6+ and CCR6– TCRγδ+ cells (middle) in the dLN of S1pr2+/− and S1pr2−/− mice. Numbers of TCRβ+ cells in
the dLN are shown on right. Data are pooled from eight independent experiments with one to three mice per group. (e)Number of IL-17+ (left) and IL-17− (right)
TCRγδ+ cells in the dLN of S1pr2+/− and S1pr2−/− mice. Data are pooled from five independent experiments with one to three mice per group. (f) Percentage of
CCR6+ TCRγδ+ in the dermis of S1pr2+/− and S1pr2−/−mice. Data are pooled from six independent experiments with one to three mice per group. (g) Percentage
of BrdU+ cells among the CCR6+ TCRγδ+ population in the dermis (left) and dLN (right) of S1pr2+/− and S1pr2−/− mice. Data are pooled from four independent
experiments with one to three mice per group. (h) Percentage of CD45.2+ cells of the indicated cell populations in irradiated CD45.1+ mice reconstituted using
neonatal thymocytes from CD45.2+ S1pr2+/− or S1pr2−/− mice. Data are pooled from five independent experiments with one to three mice per group.
(i) Representative FACS plots (left) and numbers (right) of KikGR Red+ cells among the TCRγδ+ cells in the dLN of S1pr2+/− or S1pr2−/− KikGR mice 24 h after
photoactivation of the ear tissue. Data are pooled from four independent experiments with two to four mice per group. Statistical analyses were performed
using the unpaired two-tailed Student’s t test. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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in the frequency and number of KikGR Red+ γδ T cells in the dLN
of the Cd69−/−mice (Fig. 4 g). Collectively, these data indicate that
CD69 acts to promote CCR6+ γδ T cell retention in the dermis
through regulation of S1PR1 expression and activity.
S1PR2 and CD69 cooperate to promote CCR6+ γδ T cell
retention in the dermis
Finally, we wanted to explore whether S1PR2 and CD69 coop-
erate to restrain CCR6+ γδ T cell egress from the skin. CCR6+ γδ
T cells from the dLN of S1pr2−/− mice displayed a marked de-
crease in S1PR1 expression and increase in the proportion of
CD69-expressing cells relative to control groups (Fig. 5 a). This
suggested that S1PR2 promotes retention of CD69+S1PR1lo cells in
the dermis. CD69 does not directly regulate S1PR2 function, as
WEHI231 cells overexpressing CD69 displayed comparable
S1PR2-mediated migration inhibition to EV-transduced cells
(Fig. 5 b). To test whether S1PR2 and CD69 cooperate to mediate
dermal CCR6+ γδ T cell retention, we generated Cd69−/−S1pr2−/−
mice. We found that there was a decrease in the frequency and
number of CCR6+ γδ T cells in the dermis relative to littermate
controls lacking either Cd69 or S1pr2 (Fig. 5 c). The frequency and
number of CCR6+ γδ T cells in the dLNwas similar between both
groups (Fig. 5 c). These results indicate that while mice can
maintain a similarly sized population of CCR6+ γδ T cells in the
dermis in the absence of either S1PR2 or CD69, compound loss of
both proteins overwhelms the ability of the host to compensate
for the loss of dermal CCR6+ γδ T cells caused by the increased
egress. The lack of double-deficient γδ T cell accumulation in the
dLN might be explained by enhanced S1PR1-mediated egress
from the LN in the absence of inhibition by CD69 and S1PR2.
Concluding remarks
Recent studies have highlighted the importance of TRM cells in
peripheral tissues for protection from disease (Muruganandah
et al., 2018). A principal active mechanism of tissue retention so
far defined has been expression of CD69 and antagonism of
S1PR1-mediated egress (Lee et al., 2011; Mackay et al., 2013; Skon
et al., 2013). Here we define a new mechanism of tissue resi-
dence involving expression of the migration inhibitory S1PR2
receptor. S1P was recently found to inhibit the in vitromigration
of human CD4+ and CD8+ TRM cells in an S1PR2-dependent
manner (Drouillard et al., 2018). Taking these in vitro ob-
servations and our in vivo findings together, it can be proposed
that S1PR2 will contribute to the tissue residence of some T cell
types in humans. Our work suggests a model in which S1PR2 and
CD69 cooperate to restrain afferent lymphatic entry of CCR6+ γδ
T cells, with neither system alone being sufficient to achieve
stable tissue residence of the cells (Fig. S3). Some CCR6+ γδ
T cells down-regulate CD69, perhaps in response to local signals
in the dermis, and preferentially reach the skin dLN. The in-
sufficiency of S1PR2 to antagonize this migration may be a
consequence of the relatively low level of S1PR2 expression on
dermal CCR6+ γδ T cells compared, for example, to germinal
center B cells (Fig. 2 a). Alternatively, while S1pr2 mRNA ex-
pression is maintained in dLN CCR6+ γδ T cells, it is possible that
S1PR2 protein has been down-regulated in the migratory subset
of CD69loS1PR1hi γδ T cells. Despite the increased flux of CCR6+
γδ T cells to the dLN in S1pr2−/− (and Cd69−/−) mice, there is no
change in the total number of cells in the dermis, likely due to
the increased cell proliferation compensating for the loss due to
egress. How dermal CCR6+ γδ T cells are able to sense this
Figure 3. S1PR1 promotes CCR6+ γδ T cell migration from the skin. (a) Expression of S1pr1, S1pr3, S1pr4, and S1pr5 in sorted CCR6+ TCRγδ+ cells from the
dermis or dLN. mRNA expression is pooled from two independent experiments with two or three mice per group. (b) Representative FACS plots (left) and
numbers (right) of KikGR Red+ cells among the TCRγδ+ cells in the dLN of vehicle and FTY720-treated KikGR mice 24 h after photoactivation of the ear tissue.
Data are pooled from three independent experiments with three or four mice per group. (c) Expression of S1PR1 on CCR6+ TCRγδ+ cells from the dermis or dLN
by flow cytometry. Data are representative of six mice. (d) Representative FACS plots (left) and numbers (right) of KikGR Red+ cells among the TCRγδ+ cells in
the dLN of vehicle and AUY954-treated KikGR mice 24 h after photoactivation of the skin. Data are pooled from three independent experiments with one or
two mice per group. Statistical analyses were performed using the unpaired two-tailed Student’s t test. **, P < 0.01.
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increased flux remains to be determined, with the increased
proliferation in the dermis but not dLN suggesting a local signal
might be important. Future work will also be needed to reveal
how generalizable the role of S1PR2 is in promoting leukocyte
retention in peripheral tissues. It will also be of interest to de-
termine whether local administration of an S1PR2 antagonist
may be an effective treatment for diseases such as psoriasis that
are induced by an overactive tissue-resident lymphocyte re-
sponse (Blankenbach et al., 2016).
Materials and methods
Mice
Adult C57BL/6 CD45.1+ (stock number 564) mice ≥6 wk of age
were purchased from the National Cancer Institute (NCI) or NCI
at Charles River. Sphk1f/- Sphk2−/− mice were provided by Dr.
Shaun Coughlin (University of California, San Francisco, San
Francisco, CA) and crossed to Mx1Cre mice (Kühn et al., 1995;
Pappu et al., 2007). Lyve1Cre, S1pr2Venus/+, Cd69−/−, S1pr2−/− mice
were generated as described (Lauzurica et al., 2000; Kono et al.,
2004; Shiow et al., 2006; Pham et al., 2010; Moriyama et al.,
2014). CAG::KikGRTg/+ mice were obtained from Jackson Labo-
ratories (013753) and backcrossed to C57BL/6 for at least six
generations (Nowotschin and Hadjantonakis, 2009). Mice were
housed in a specific pathogen–free environment in the Labora-
tory Animal Research Center at the University of California, San
Francisco (UCSF). All animal procedures were approved by the
UCSF Institutional Animal Care and Use Committee.
Tissue preparation
LNs and ear skin were digested as described previously
(Gray et al., 2013). LNs were digested with rotation for
Figure 4. CD69 restrains S1PR1 expression and limits CCR6+ γδ T cell migration from the skin. (a) Expression of Cd69 in sorted CCR6+ TCRγδ+ cells from
the dermis or dLN. mRNA expression is pooled from two independent experiments with two or three mice per group. (b) Expression of S1PR1 and CD69 on
CCR6+ TCRγδ+ cells from the dermis or dLN by flow cytometry. Data are representative of four independent experiments with one to three mice per ex-
periment. (c) Expression of S1PR1 on CCR6+ TCRγδ+ cells from the dermis or dLN in Cd69+/− and Cd69−/− mice by flow cytometry. Data are representative of
three independent experiments with one to three mice per experiment. (d) Representative FACS plots of CCR6+ TCRγδ+ cells (top) and numbers of CCR6+ and
CCR6– TCRγδ+ cells (bottom left) in the dLN of Cd69+/− and Cd69−/− mice. Numbers of TCRβ+ cells in the dLN are shown on bottom right. Data are pooled from
five independent experiments with one to three mice per group. (e) Percentage of CCR6+ TCRγδ+ in the dermis of Cd69+/− and Cd69−/− mice. Data are pooled
from three independent experiments with one to three mice per group. (f) Percentage of BrdU+ cells among the CCR6+ TCRγδ+ population in the dermis (left)
and dLN (right) of Cd69+/− and Cd69−/− mice. Data are pooled from two independent experiments with one or two mice per group. (g) Representative FACS
plots (left) and numbers (right) of KikGR Red+ cells among the TCRγδ+ cells in the dLN of Cd69+/− or Cd69−/− KikGR mice 24 h after photoactivation of the ear
tissue. Data are pooled from five independent experiments with one to three mice per group. Statistical analyses were performed using the unpaired two-tailed
Student’s t test. *, P < 0.05; **, P < 0.01.
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20–30 min at 37°C with 67 µg/ml Liberase TM (Roche Applied
Science) and 20 µg/ml DNaseI (Sigma-Aldrich). Ears were split
into dorsal and ventral halves and were digested in 2 mg/ml
Dispase (Gibco). Separated epidermal and dermal sheets were
digested for 60–120 min at 37°C, with rotation, in DMEM con-
taining penicillin–streptomycin, Hepes buffer, 85 µg/ml Lib-
erase TM, 100 µg/ml DNaseI, 0.5 mg/ml hyaluronidase (Sigma-
Aldrich), and 2% FCS. Alternatively, whole ear skin was minced
and digested with liberase, DNase I, and hyaluronidase as de-
scribed above. Digestion enzymes were quenched by the addi-
tion of 5 mMEDTA and 1% serum. All tissues were disaggregated
by passage through a 70-µm or 100-µm nylon sieve (BD
Bioscience).
Transwell migration assay
LN and ear skin were prepared as described above and re-
suspended in RPMI medium containing 10 mM Hepes and 2%
fatty acid–free BSA. Lymphocytes from ear skin samples were
further isolated using Lympholyte-M Separation Media (Ce-
darlane Labs) and were rested for 40 min in media containing
1 ng/ml recombinant mouse IL-7. Cells were then tested for
transmigration across uncoated 5-µm transwell filters for 3 h
to medium alone or to media containing 0.1 µg/ml CXCL12. In
some cases, cells were incubated with medium containing 0.1
µg/ml CXCL12 and 1 nM, 10 nM, or 100 nM S1P with or
without 10 µM of the S1PR2 antagonist JTE-013 (Tocris Bio-
science). WEHI231 cells in which a fraction of cells expressed
S1PR2-Thy1.1 were transduced with EV-GFP or CD69-GFP
retroviruses, rested for 1 d, and then tested for migration
across uncoated 5-µm transwell filters for 3 h to the agents
described above. The response of Thy1.1+ GFP+ cells was
studied.
Neonatal thymocyte transfer and BM chimeras
A total of 5–10 × 106 thymocytes harvested within 48 h of birth
were transferred i.v. to congenic recipients lethally irradiated
with a split dose of 1,300 rad. The next day, 3–6 × 106 congenic
BM cells were transferred. Recipient mice were analyzed ≥8
wk later.
FTY720 and AUY954 treatment and in vivo BrdU labeling
Mice were treated with FTY720 (or saline) at 1 mg/kg i.v. every
2–3 d and sacrificed 1 wk after first treatment. Mice were treated
with AUY954 (Cellagen Technology) at 3 mg/kg orally at time 0
and 12 h and analyzed 1 d after first treatment. For experiments
involving BrdU, mice were maintained on drinking water con-
taining BrdU (0.7 mg/ml) and glucose (1%) until analysis.
LN entry blockade
25 × 106 T cells transduced with EV-Thy1.1 or S1PR2-Thy1.1
retroviruses were transferred to CD45 congenically distinct re-
cipient mice. The next day, mice were treated with integrin-
neutralizing antibodies administered i.p. at 100 µg per mouse.
The anti-αL (cloneM17/4, rat IgG2a) and anti-α4 (clone PS/2, rat
IgG2b) neutralizing antibodies were from Bio X Cell. Mice were
analyzed at the time of treatment or 18 h later.
Photoconversion
A 415-nm Silver LED light source with a 1.5-mm (core diameter)
light guide and collimating adaptor (Prizmatix) was used for
photoconversion. Mice were anesthetized with ketamine, and
ventral ear skin was exposed for 5–10 min to 415-nm violet light
(∼1 cm diameter). Ear draining (cervical) LNs were analyzed 1 d
later. For some experiments, clipped abdominal skin was also
exposed to 415-nm violet light (∼1 cm diameter) for 5 min. In
these cases, the inguinal, axillary, and brachial LNs were pooled
with the auricular LN for the analysis. Flow cytometry was used
to assess photoconversion as previously described (Gray et al.,
2013).
Antibodies for flow cytometry
The following antibodies were used for flow: PE–
indotricarbocyanine (PE-Cy7) anti-CD69 (H1.2F3), Biotin
anti-CD69 (H1.2F3), Pacific Blue anti-TCRβ (H57-597; all from
BioLegend); allophycocyanin (APC) anti-CCR6 (140706), PE-
Cy7 anti-TCRγδ (GL3), FITC anti-TCRγδ (GL3), FITC anti-Vγ4
(UC3-10A6), PE-Cy7 anti-Vγ4 (UC3-10A6), Brilliant Violet
605 (BV605), streptavidin (110738; all from BD Biosciences);
FITC anti-BrdU (BU20A; from eBioscience); and PerCP-
Cy5.5 anti-CD45.2 (65–0454-U100; Tonbo Biosciences). For
Figure 5. CD69 and S1PR2 cooperate to restrain CCR6+ γδ T cell migration from the skin. (a) Expression of S1PR1 and CD69 on CCR6+ TCRγδ+ cells from
the dLN of S1pr2+/− and S1pr2−/− mice by flow cytometry. Data are representative of two independent experiments with one to three mice per experiment.
(b) Percentage migration of S1PR2-Thy1.1+ WEHI231 cells transduced with control (EV-GFP) or CD69-GFP expressing retrovirus, to the indicated stimuli. Data
are representative of two to four independent experiments with three wells per condition for experiment. (c) Percentage of CCR6+ TCRγδ+ cells in the dermis
(left) and dLN (right) of control and Cd69−/−S1pr2−/− mice. Data are pooled from five independent experiments with one to three mice per group. Statistical
analyses were performed using the unpaired two-tailed Student’s t test. *, P < 0.05; ***, P < 0.001.
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S1PR1 staining, cells were incubated with a rat monoclonal an-
tibody raised against an S1PR1–N-terminal peptide as previously
described (R&D Systems; Arnon et al., 2011). For intracellular
staining of IL-17A, cells were stimulated for 2 h with 50 ng/ml
PMA (Sigma-Aldrich) and 1 µg/ml ionomycin (EMD Biosciences)
in brefeldin A (BD Biosciences). Cells were stained with the
fixable viability dye eFluor 780 according to the manufacturer’s
instructions (eBioscience) for the exclusion of dead cells, non-
specific binding was blocked with anti-CD16/32 (clone 2.4G2;
University of California, San Francisco, Hybridoma Core) in 5%
normal mouse and rat serum, and then cells were stained for
surface antigens and fixed with BD Cytofix Buffer. After per-
meabilization with Perm/Wash reagent (BD Biosciences), cells
were stained with anti–IL-17A (eBio17B7; eBioscience). Flow cy-
tometry data were acquired on a BD LSRII with FACSDiva soft-
ware and were analyzed with FlowJo software (TreeStar).
Real-time PCR
Total RNA was isolated and converted to cDNA as described
previously (Gray et al., 2011). A StepOnePlus real-time PCR
system (Applied Biosystems) with iTaq SYBR Green Supermix
(Bio-Rad) and the appropriate primer pairs (Integrated DNA
Technologies) were used for real-time PCR. The following pri-
mers were used: Cd69 forward, 59-TGGTCCTCATCACGTCCT
TAATAA-39; reverse, 59-TCCAACTTCTCGTACAAGCCTG-39.
S1pr1 forward, 59-GTGTAGACCCAGAGTCCTGCG-39; reverse, 59-
AGCTTTTCCTTGGCTGGAGAG-39. S1pr2 forward, 59-GGCCTA
GCCAGTGCTCAGC-39; reverse, 59-CCTTGGTGTAATTGTAGT
GTTCCAGA-39. S1pr3 forward, 59-GGAGCCCCTAGACGGGAGT-
39; reverse, 59-CCGACTGCGGGAAGAGTGT-39. S1pr4 forward, 59-
CCTGGAACTCACTTTATAGACCAGG-39; reverse, 59-AGAAAG
CGTGCCATAGGCAG-39. S1pr5 forward, 59-GAGTGCCGGTTACAG
GAGACTT-39; reverse, 59-CGCTGCTGTGTCCTGCC-39; Hprt for-
ward, 59-AGGTTGCAAGCTTGCTGGT-39; reverse, 59-TGAAGT
ACTCATTATAGTCAAGGGCA-39.
Statistical analysis
Results represent the mean ± SEM unless indicated otherwise.
Statistical significance was determined by the unpaired Stu-
dent’s t test. Statistical analyses were performed using Prism
GraphPad software v5.0. (*, P < 0.05; **, P < 0.01; ***, P < 0.001).
Online supplemental material
Fig. S1 shows an example flow-cytometric gating scheme to
identify dermal CCR6+ γδ T cells and the percentage of CCR6+ γδ
T cells in the dermis and dLN of mice lacking lymphatic endo-
thelial cell–derived S1P. Fig. S2 shows additional phenotyping of
S1pr2−/− and Cd69−/− mice and includes data revealing a role for
S1PR2 in opposing T cell egress from the LN. Fig. S3 shows a
model of how S1PR2 and CD69 mediated regulation of CCR6+ γδ
T cell migration from the skin.
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